Summary
A combination of bleomycin, vincristine, mitomycin-C, and cisplatin was used to treat 39 patients with advanced and/or recurrent cervical cancer. Twenty patients showed an objective response (complete or partial) with a mean duration of 14.8 months. The overall response rate was 58.8%. Twelve patients are still alive and in remission 7–36 months after the start of chemotherapy. Toxicity was acceptable.
Similar content being viewed by others
References
Alberts DS, Martimbeau PW, Surwit EA, Oishi N (1981) Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials 4:313–316
Belinson JL, Stewart JA, Richards AL, McClue M (1985) Bleomycin, vincristine, mitomycin-C and cisplatin in the management of gynecological squamous cell carcinomas. Gynecol Oncol 20:387–393
Forney JP, Morrow CP, Di Saia PJ, Futoran RJ (1975) Seven — drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract. Am J Obstet Gynecol 123:748–752
Freedman RS, Herson J, Wharton JT, Rutledge FN (1980) Single-agent chemotherapy for recurrent carcinoma of the cervix. Cancer Clin Trials 3:345–350
Piver MS, Barlow JJ, Lele SB, Maniccia M (1984) Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix. Gynecol Oncol 18: 313–319
Thigpen T, Vance RB, Balducci L, Blessing J (1981) Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma. Cancer 48:658–665
Tropé C, Johnsson JE, Simonsen E, Sigurdsson K, Stendahl U, Mattsson W, Gullberg B (1983) Bleomycin — mitomicin-C in advanced carcinoma of the cervix. A third look. Cancer: 591–593
Wheelock JB, Krebs HB, Goplerud DR, Myers M (1985) Cis-Platinum, doxorubicin and methotrexate treatment for recurrent cervical cancer. Obstet Gynecol 66: 410–412
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lahousen, M., Pickel, H. & Tamussino, K. Chemotherapy for advanced and/or recurrent cervical cancer. Arch. Gynecol. 240, 247–252 (1987). https://doi.org/10.1007/BF02134075
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02134075